InfuSystem Holdings Inc (NYSEAMERICAN:INFU) Director Christopher R. Sansone purchased 14,290 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was bought at an average cost of $4.96 per share, with a total value of $70,878.40. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Christopher R. Sansone also recently made the following trade(s):

  • On Friday, August 23rd, Christopher R. Sansone acquired 27,792 shares of InfuSystem stock. The stock was acquired at an average price of $4.93 per share, with a total value of $137,014.56.
  • On Friday, August 16th, Christopher R. Sansone acquired 16,300 shares of InfuSystem stock. The stock was acquired at an average price of $4.96 per share, with a total value of $80,848.00.

InfuSystem stock traded up $0.05 during mid-day trading on Friday, hitting $5.05. The company’s stock had a trading volume of 21,309 shares, compared to its average volume of 23,433. InfuSystem Holdings Inc has a 1 year low of $2.94 and a 1 year high of $5.21.

InfuSystem (NYSEAMERICAN:INFU) last issued its quarterly earnings data on Wednesday, August 14th. The medical instruments supplier reported $0.02 earnings per share for the quarter. The business had revenue of $19.72 million during the quarter.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. White Pine Capital LLC boosted its position in shares of InfuSystem by 23.3% during the second quarter. White Pine Capital LLC now owns 494,670 shares of the medical instruments supplier’s stock worth $2,127,000 after buying an additional 93,420 shares during the period. AWM Investment Company Inc. boosted its position in shares of InfuSystem by 9.1% during the second quarter. AWM Investment Company Inc. now owns 1,855,362 shares of the medical instruments supplier’s stock worth $7,978,000 after buying an additional 155,092 shares during the period. Kennedy Capital Management Inc. purchased a new position in shares of InfuSystem during the first quarter worth $3,374,000. Finally, FineMark National Bank & Trust boosted its position in shares of InfuSystem by 5.9% during the first quarter. FineMark National Bank & Trust now owns 225,396 shares of the medical instruments supplier’s stock worth $1,129,000 after buying an additional 12,500 shares during the period.

InfuSystem Company Profile

InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Featured Article: CBOE Russell 2000® Volatility Index

Insider Buying and Selling by Quarter for InfuSystem (NYSEAMERICAN:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.